The National Institutes of Health (NIH) is offering a Small Business Innovation Research (SBIR) opportunity focused on the development of devices, diagnostic technologies, or digital health tools aimed at the treatment, detection, and diagnosis of pediatric and rare cancers. Proposals must adhere to specific guidelines, including a budget of up to $300,000 for a duration of 12 months, with an additional $6,500 available for Technical Assistance for Business Applications (TABA) if requested; fast track and direct-to-Phase II proposals are not permitted, and non-exempt human subjects research is prohibited. This initiative addresses the urgent need for innovative solutions in a field where development has lagged, as pediatric cancers and rare cancers represent significant health challenges, with approximately 9,550 children expected to be diagnosed with cancer in the U.S. in 2025. Interested applicants should note that the application deadline is September 26, 2025, and further details can be found at the provided source link: https://www.sbir.gov/topics/12005.